+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Excipient Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 184 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968715
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical excipient market is a critical enabler for advancing drug formulation and delivery, ensuring safe, effective, and consistent medicines reach global populations. Senior decision-makers face dynamic pressures to increase quality, compliance, and innovation while navigating evolving supply and regulatory landscapes.

Market Snapshot: Pharmaceutical Excipient Market Size and Growth

The pharmaceutical excipient market expanded from USD 9.22 billion in 2024 to USD 9.89 billion in 2025 and is expected to reach USD 16.98 billion by 2032, demonstrating a CAGR of 7.93%. This upward trajectory highlights surging demand for excipients that enable advanced drug delivery technologies, improve bioavailability, and support emerging therapeutic platforms. Growing complexity in pharmaceutical products and the push for optimized performance reinforce the essential role excipients play. As manufacturers align with patient-centric and regulatory-driven needs, the pharmaceutical excipient market is positioned for significant growth and strategic value across the healthcare supply chain.

Scope & Segmentation of the Pharmaceutical Excipient Market

Strategic segmentation enables precise market analysis and better decision-making, supporting operational excellence and tailored innovation throughout the value chain. Diverse segments are addressed to meet a wide range of pharmaceutical requirements:

  • Type: Inorganic excipients include calcium carbonate, calcium phosphate, calcium sulfate, halites, and metal oxides. Organic excipients encompass carbohydrates (e.g., cellulose, starch, sugars); oleochemicals (e.g., fatty alcohols, glycerin, mineral stearates); petrochemicals (e.g., acrylic polymers, glycols, mineral hydrocarbons, povidones); and proteins, each contributing distinct properties.
  • Formulation: Excipients are key in oral formats (hard gelatin and soft gelatin capsules, liquids, tablets), parenteral, and topical dosage forms, supporting broad therapy areas and individualized drug delivery demands.
  • Function: Functional roles include binders, coating agents, colorants, disintegrants, emulsifying agents, fillers and diluents, flavoring agents and sweeteners, lubricants and glidants, preservatives, and agents for suspension and viscosity management.
  • End-User: User groups span pharmaceutical and biopharmaceutical firms, contract manufacturing organizations focused on flexible production, and research laboratories driving new drug formulation approaches.
  • Distribution Channel: Channels consist of offline methods such as direct sales and distributor partnerships, as well as online platforms expanding regional reach and improving supplier responsiveness.
  • Regional Coverage: The Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East, and Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan) offer vast opportunities for excipient suppliers, shaped by market maturity, regulatory frameworks, and evolving healthcare needs.

Key Takeaways for Decision-Makers

  • The evolution of excipients from basic additives to critical formulation enablers is increasing drug stability, performance, and patient adherence across pharmaceutical pipelines.
  • Demand for innovative excipients is rising alongside newer drug formats such as biologics and personalized medicines, emphasizing the need for tailored solutions compatible with complex molecules.
  • Greater regulatory scrutiny is prompting manufacturers to implement advanced traceability and analytics, reinforcing supply chain transparency as a core quality and compliance driver.
  • Collaborative efforts among formulation scientists, chemists, and regulatory teams are accelerating time-to-market, paving the way for agile product development strategies.
  • Sustainable sourcing and adoption of bio-based excipients are becoming standard practice as industry stakeholders respond to environmental regulations and incentives.
  • The shift toward digital distribution channels and more diversified sourcing allows manufacturers and suppliers to respond quickly to regional market demands and changing customer preferences.

Tariff Impact on the Pharmaceutical Excipient Market

Recent tariff changes in the United States have influenced the sourcing and cost structure of excipient raw materials and finished products. Companies are strengthening their procurement strategies by assessing supply origins, expanding local production capabilities, and building resilience to mitigate trade-related risks. Such actions help secure continuous product availability and adapt to regulatory shifts.

Methodology & Data Sources

This outlook is based on interviews with industry experts, formulation specialists, supply chain executives, and regulatory authorities. Additional insights are gained from comprehensive reviews of market reports, patent literature, and corporate disclosures, ensuring reliable and actionable intelligence for executive planning.

Why This Report Matters

  • Supports growth strategies by delivering in-depth segmentation and actionable insights tailored to a dynamic landscape of drug formulation and delivery technology.
  • Enables resilient supply chain management and operational agility by addressing regulatory and sourcing challenges specific to the pharmaceutical excipient sector.
  • Empowers leadership decisions on investment, partnership, and regional expansion, ensuring long-term competitiveness as the excipient market evolves.

Conclusion

As innovation, compliance, and sustainability rise in importance, the pharmaceutical excipient market provides executives with frameworks to enhance formulation quality, optimize supply networks, and maintain a strong position in an increasingly complex industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Advancements in silica-based glidants optimizing powder flow for high-speed tablet production under GMP conditions
5.2. Shift towards plant-based and clean-label excipients as patient demand for natural formulations increases
5.3. Adoption of co-processed excipients driving direct compression formulation efficiencies in tablet manufacturing
5.4. Integration of real-time analytical technologies in excipient manufacturing for continuous process verification
5.5. Rising regulatory focus on quality by design to standardize excipient production across global markets
5.6. Emergence of biodegradable polymer excipients to meet sustainability targets and reduce environmental impact
5.7. Supply chain diversification strategies to mitigate raw material shortages in pharmaceutical excipient markets
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pharmaceutical Excipient Market, by Type
8.1. Inorganic
8.1.1. Calcium Carbonate
8.1.2. Calcium Phosphate
8.1.3. Calcium Sulfate
8.1.4. Halites
8.1.5. Metal Oxides
8.2. Organic
8.2.1. Carbohydrates
8.2.1.1. Cellulose
8.2.1.2. Starch
8.2.1.3. Sugars
8.2.2. Oleochemicals
8.2.2.1. Fatty Alcohols
8.2.2.2. Glycerin
8.2.2.3. Mineral Stearates
8.2.3. Petrochemicals
8.2.3.1. Acrylic Polymers
8.2.3.2. Glycols
8.2.3.3. Mineral Hydrocarbons
8.2.3.4. Povidones
8.2.4. Proteins
9. Pharmaceutical Excipient Market, by Formulation
9.1. Oral Formulations
9.1.1. Hard Gelatin Capsules
9.1.2. Liquid Formulations
9.1.3. Soft Gelatin Capsules
9.1.4. Tablets
9.2. Parenteral Formulations
9.3. Topical Formulations
10. Pharmaceutical Excipient Market, by Function
10.1. Binders
10.2. Coating Agents
10.3. Colorants
10.4. Disintegrants
10.5. Emulsifying Agents
10.6. Fillers & Diluents
10.7. Flavoring Agents & Sweeteners
10.8. Lubricants & Glidants
10.9. Preservatives
10.10. Suspending & Viscosity Agents
11. Pharmaceutical Excipient Market, by End-User
11.1. Biopharmaceutical Companies
11.2. Contract Manufacturing Organizations
11.3. Pharmaceutical Companies
11.4. Research Laboratories
12. Pharmaceutical Excipient Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Pharmaceutical Excipient Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Pharmaceutical Excipient Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Pharmaceutical Excipient Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ABITEC Corporation
16.3.2. Actylis
16.3.3. Archer Daniels Midland Company
16.3.4. ARMOR PROTEINES S.A.S. by Savencia Group
16.3.5. Asahi Kasei Corporation
16.3.6. Ashland Inc.
16.3.7. BASF SE
16.3.8. BIOGRUND GmbH
16.3.9. Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
16.3.10. Clariant AG
16.3.11. Colorcon Inc.
16.3.12. Corel Pharma Chem Private Limited
16.3.13. Croda International Plc
16.3.14. Darling Ingredients, Inc.
16.3.15. DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
16.3.16. DuPont de Nemours, Inc.
16.3.17. Evonik Industries AG
16.3.18. Fuji Chemical Industries Co., Ltd.
16.3.19. GATTEFOSSE SAS
16.3.20. Innophos Holdings, Inc. by Iris Parent LLC
16.3.21. International Flavors & Fragrances Inc.
16.3.22. JRS PHARMA GmbH + Co. KG
16.3.23. Kerry Group P.L.C.
16.3.24. Lipoid GmbH
16.3.25. Lubrizol Corporation
16.3.26. L’AIR LIQUIDE S.A.
16.3.27. Mallinckrodt plc
16.3.28. MEGGLE GmbH & Co. KG
16.3.29. Merck KGaA
16.3.30. Nagase & Co., Ltd.
16.3.31. Nipon Soda Co., Ltd.
16.3.32. NOF Corporation
16.3.33. Omya International AG
16.3.34. Peter Greven GmbH & Co. KG
16.3.35. Roquette Frères S.A.
16.3.36. Shin-Etsu Chemical Co., Ltd.
16.3.37. Solvay S.A.
16.3.38. SPI Pharma, Inc.
16.3.39. Sumitomo Seika Chemicals Company, Limited
16.3.40. Thermo Fisher Scientific Inc.
16.3.41. Vanderbilt Minerals LLC
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Pharmaceutical Excipient market report include:
  • ABITEC Corporation
  • Actylis
  • Archer Daniels Midland Company
  • ARMOR PROTEINES S.A.S. by Savencia Group
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc. by Iris Parent LLC
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Lipoid GmbH
  • Lubrizol Corporation
  • L’AIR LIQUIDE S.A.
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay S.A.
  • SPI Pharma, Inc.
  • Sumitomo Seika Chemicals Company, Limited
  • Thermo Fisher Scientific Inc.
  • Vanderbilt Minerals LLC

Table Information